GridX, a biotechnology investment fund and company builder based in Buenos Aires, Argentina, is embarking on an exciting international roadshow.
The tour will showcase 21 groundbreaking startups from Latin America, aiming to bring their biotech innovations to investors across the United States.
Tour Details and Key Dates
Starting this week, the roadshow will kick off in Tulsa on April 23, followed by stops in New York on April 29, and wrapping up in San Francisco on May 5.
This event is designed to connect some of the most promising biotech ventures from Latin America with U.S. capital markets, creating opportunities for cross-border investment.
A Strong Network of Industry Support
The roadshow is supported by key industry players, including Amazon Web Services, Atento Capital in Tulsa, and SynBioBeta.
Notable figures like SynBioBeta’s founder, John Cumbers, and Po Bronson, managing director of Indie Bio—one of the world’s top biotech accelerators—are lending their expertise to the event.
Focus Areas of the Startups
The selected startups span four key biotech sectors:
- Human Health
- Agri-food and Land Use
- Bio-industry
- Deep Biotech
These companies are leveraging Latin America’s rich biodiversity and growing scientific talent to develop cutting-edge solutions that have the potential to revolutionize industries worldwide.
GridX’s Expanding Portfolio
GridX has built an impressive portfolio of 81 biotech startups, with founding teams hailing from seven Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Uruguay.
As the sector grows, GridX’s initiative is poised to accelerate the international visibility of Latin American biotech.
What’s next? The roadshow promises to open new doors for innovation, investment, and collaboration between Latin America and North America in the biotech space.